TY - JOUR T1 - Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis JO - Actas Dermo-Sifiliográficas T2 - AU - Rodríguez-Zuñiga,M.J.M. AU - García-Perdomo,H.A. AU - Ortega-Loayza,A.G. SN - 15782190 M3 - 10.1016/j.adengl.2019.03.017 DO - 10.1016/j.adengl.2019.03.017 UR - https://www.actasdermo.org/en-association-between-hidradenitis-suppurativa-metabolic-articulo-S1578219019301118 AB - BackgroundRecent studies have shown a relationship between hidradenitis suppurativa (HS) and metabolic syndrome (MS), but the literature offers no meta-analysis restricted to studies that have been adjusted for confounders. ObjectiveTo determine the association between HS and MS. MethodsA systematic review and meta-analysis of observational studies on HS and MS in adults. We searched MEDLINE, SCOPUS, SCIELO, Google Scholar, Science Direct and LILACS from the inception of the databases to January 2016. We performed a random effects model meta-analysis for studies reporting adjusted and crude odds ratios (ORs) with 95% CIs. A subgroup analysis was related to the type of HS patient (general patients vs hospital patients) and age group (adults vs children and adults). ResultsFive studies including 3950 HS patients were analyzed. We found that MS was present in 9.64% of HS patients (OR, 1.82; 95% CI, 1.39–2.25). Studies from tertiary care hospital dermatology clinics (OR, 2.82; 95% CI, 0.58–5.06) reported a greater risk for MS than studies carried out in patients treated outside hospitals (OR, 1.78; 95% CI, 1.34–2.22). Studies that included pediatric populations reported a significant association (OR, 2.10; 95% CI, 1.58–2.62). LimitationFew of the included studies reported adjusted ORs. ConclusionsHS patients have an increased risk for MS. Clinicians should consider screening HS patients for metabolic risk factors. ER -